top of page
  • White Facebook Icon
  • White Twitter Icon
Search

M&A Transaction

Aug 7, 2024
1 min read

Updated: Sep 19, 2024

Scope Law acts as Swiss legal counsel to the shareholders of Pharma-Data S.A. (Greece) on its sale to Rosemont Pharmaceuticals Ltd. (United Kingdom).


Pharma-Data specialises in Research and Development and development of Value-Added Medicinal Drug Products for Europe and USA. Rosemont is a leading developer, manufacturer and distributor of liquid medicines for over 50 years.


The acquisition complements Rosemont’s product development capability in house as well as improving Rosemont’s capability to develop other dosage forms and modified release oral liquids.


 
 
 

Recent Posts

See All
Financing Round

Scope Law advised SquaredData AG (ETFBOOK), Zurich, on its USD 13 million funding round led by Expedition Growth Capital, with participation from existing investor BlackFin Capital Partners. ETFBOOK i

 
 
 
Financing Round

Scope Law advised Innovire AG (AVIAN), Zurich, on its USD 2.6 million pre-seed financing round led by Founderful. AVIAN develops an AI-powered thermal monitoring platform for the early detection of

 
 
 
Ranking

For the fifth consecutive year, Scope Law has been ranked as one of the top Swiss law firms by the renowned business magazines BILANZ and PME. We are very pleased to be included in the ranking again.

 
 
 

Comments

bottom of page